FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Roberts Jonathan C
2. Issuer Name and Ticker or Trading Symbol

CVS HEALTH Corp [ CVS ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
EVP & President, CVS Caremark
(Last)          (First)          (Middle)

ONE CVS DRIVE
3. Date of Earliest Transaction (MM/DD/YYYY)

2/16/2017
(Street)

WOONSOCKET, RI 02895-
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   2/16/2017     M    61196   A $36.23   89955.1293   D    
Common Stock   2/16/2017     S (1)    61196   D $80.00   28759.1293   D    
Common Stock (pep)                  11702.5082   D    
Common Stock (restricted)                  60753   D    
ESOP Common Stock                  5319.994   I   By ESOP  
Stock Unit                  113725.4939   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option   $36.23   2/16/2017     M         61196    4/1/2011   (2) 4/1/2017   Common Stock   61196   $0   0   D    
Phantom Stock Credits   $1.00                      (3)   (3) Common Stock   1416.5562     1416.5562   D    
Stock Option   $34.96                    4/1/2012   (4) 4/1/2018   Common Stock   85743     85743   D    
Stock Option   $45.07                    4/2/2013   (5) 4/2/2019   Common Stock   77639     77639   D    
Stock Option   $54.53                    4/1/2014   (6) 4/1/2020   Common Stock   68844     68844   D    
Stock Option   $74.29                    4/1/2015   (7) 4/1/2021   Common Stock   73433     73433   D    
Stock Option   $45.93                    9/4/2015   (8) 9/4/2022   Common Stock   108870     108870   D    
Stock Option   $102.26                    4/1/2016   (9) 4/1/2022   Common Stock   68482     68482   D    
Stock Option   $104.82                    4/1/2017   (10) 4/1/2023   Common Stock   161318     161318   D    

Explanation of Responses:
( 1)  All sales were effected pursuant to a Rule 10b5-1 plan.
( 2)  Option became exercisable in three annual installments, commencing 4/1/2011.
( 3)  Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
( 4)  Option became exercisable in four equal annual installments, commencing 4/1/2012.
( 5)  Option became exercisable in four equal annual installments, commencing 4/2/2013.
( 6)  Option became exercisable in four equal annual installments, commencing 4/1/2014.
( 7)  Option became exercisable in four equal annual installments, commencing 4/1/2015.
( 8)  Option became exercisable in three equal annual installments, commencing 9/4/2015.
( 9)  Option became exercisable in four equal annual installments, commencing 4/1/2016.
( 10)  Option becomes exercisable in four equal annual installments, commencing 4/1/2017.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Roberts Jonathan C
ONE CVS DRIVE
WOONSOCKET, RI 02895-


EVP & President, CVS Caremark

Signatures
Jonathan C. Roberts 2/17/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
CVS Health (NYSE:CVS)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more CVS Health Charts.
CVS Health (NYSE:CVS)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more CVS Health Charts.